AI Imaging and Remote Monitoring Add a Digital Layer to PAD Management
Peripheral Artery Disease Market size was valued at USD 5.49 billion in 2025 and is estimated at USD 5.9 billion in 2026. According to Polaris Market Research, it is projected to reach USD 10.53 billion by 2034, growing at a CAGR of 7.50% from 2026 to 2034. The surging prevalence of diabetes and hypertension, key risk factors for PAD, is contributing to a larger patient base and making timely diagnosis and treatment increasingly critical.
Understanding the Condition and Care Pathway
Peripheral artery disease is a circulatory condition in which narrowed arteries, commonly caused by atherosclerosis, reduce blood flow to the limbs. The Peripheral Artery Disease Market covers diagnostic imaging systems, angioplasty devices, stents, atherectomy tools and pharmacological therapies that improve circulation, relieve symptoms and prevent complications such as ulcers or limb amputation.
Diagnosis typically begins with a review of history and risk factors such as smoking, diabetes, hypertension and high cholesterol, followed by the ankle-brachial index. Doppler ultrasound, CT angiography, MR angiography and conventional angiography then identify the location and severity of blockages. Treatment ranges from medication and lifestyle changes to endovascular interventions and surgery, with regular imaging used to monitor recurrence.
Key Growth Drivers
Diabetes and hypertension. According to the International Diabetes Federation, 589 million adults aged 20 to 79 live with diabetes, a number projected to reach 853 million by 2050. Diabetes raises the risk of poor circulation, neuropathy and delayed wound healing, while hypertension accelerates atherosclerosis. Together they push more people toward PAD diagnosis and treatment, increasing demand for detection tools, interventional devices and long-term management.
An aging population. Older adults face higher PAD risk because of arterial stiffening and cumulative vascular wear. According to the US National Health and Nutrition Examination Survey, 70% of people aged 65 and above are affected by hypertension. This demographic shift sustains demand for minimally invasive procedures and home-based care that support faster recovery.
Lifestyle factors and screening. Poor diet, inactivity and rising obesity are increasing atherosclerotic disease, while public health programs aimed at early detection are helping identify PAD sooner and reduce downstream complications.
Technology advances. Drug-coated balloons, drug-eluting stents, bioresorbable implants and atherectomy systems are lowering restenosis risk and speeding recovery. In November 2024, the FDA approved Abbott’s dissolvable stent technology for PAD, which supports the artery during healing and then dissolves, reducing complications tied to permanent implants. AI-assisted diagnosis, advanced vascular imaging and remote monitoring platforms add further precision.
Challenges
Advanced devices such as drug-eluting stents, atherectomy systems and bioresorbable stents are expensive, limiting use in price-sensitive and underinsured settings. Mild or absent early symptoms mean PAD is often found only after it has progressed to critical limb ischemia, and reocclusion after angioplasty or stenting can require repeat procedures.
Explore The Complete Comprehensive Report Here : https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market
Segment Insights
By treatment type, devices accounted for 61.8% of revenue in 2025, driven by growing use of stents, angioplasty balloons and atherectomy devices in minimally invasive surgery. Clinicians increasingly prefer device-based approaches for faster recovery and shorter hospital stays. Drugs, including antiplatelet agents, statins and antihypertensives, remain essential for long-term management and for patients unfit for surgery.
By distribution channel, hospital pharmacies led with a 54.3% share in 2025, reflecting high patient inflow for complex interventions such as angioplasty and bypass surgery. Retail pharmacies are expected to grow significantly as early-stage diagnoses rise and older adults manage chronic vascular disease at home.
By end user, hospitals held the largest share in 2025 because of advanced diagnostics, vascular surgeons and multidisciplinary teams for severe cases. Ambulatory surgical centers are projected to grow fastest, supported by demand for same-day, cost-effective minimally invasive procedures and favorable reimbursement.
Regional Outlook
North America dominated the Peripheral Artery Disease Market with a 42.7% revenue share in 2025, supported by early access to screening, strong patient awareness, robust reimbursement and widespread availability of drug-eluting stents and atherectomy systems. The U.S. accounted for 78.4% of the regional market, helped by its geriatric population, high comorbidity rates and proactive adoption of interventional procedures.
Asia Pacific is expected to record the fastest growth, with a CAGR of 8.9% from 2026 to 2034, as healthcare systems expand and awareness rises. China holds a significant share of the region, driven by high diabetes, smoking and hypertension rates and growing reimbursement for minimally invasive care. Europe also posted significant growth in 2025, with structured disease management programs and high adoption of drug-coated balloons and stenting.
Competitive Landscape
The landscape is marked by intense innovation, mergers and acquisitions, and alliances between device developers and healthcare providers. Companies are broadening vascular portfolios and investing in drug-coated balloons, atherectomy and revascularization devices, alongside digital health tools. Leading participants include Abbott, AngioDynamics, B. Braun SE, Bayer AG, BD, Biotronik, Boston Scientific Corporation, Cardinal Health, Endologix LLC, iVascular, Johnson & Johnson, Koninklijke Philips N.V., Medtronic and Terumo Corporation.
A notable recent move came in April 2026, when Stryker signed a definitive agreement to acquire Amplitude Vascular Systems, a privately held company developing a next-generation intravascular lithotripsy platform designed to treat calcified peripheral arterial disease.
Peripheral Artery Disease Market growth will continue to be shaped by rising cardiovascular risk, minimally invasive innovation and earlier diagnosis. As stent technology, drug delivery, AI-assisted imaging and personalized treatment mature, manufacturers and providers that make advanced care more affordable and accessible stand to benefit from the expanding patient base.
More Trending Latest Reports By Polaris Market Research:
Subcutaneous Drug Delivery Devices Market
Lower Extremity Implants Market
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- الألعاب
- Gardening
- Health
- الرئيسية
- Literature
- Music
- Networking
- أخرى
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness